R&D spending in Spain declined 5.6% in 2012 to €13,392 million ($17,169 million), or 1.3% of GDP. R&D spending by the business sector fell 4.1% to make up 53% of total R&D spending. Higher education R&D spending declined 7.2% to make up 28%, and public sector R&D spending fell 7.4% to account for 19%. Business, […]

The China Food and Drug Administration published a draft of an update to the 2009 Food Safety Law last month. Among the additions is a statement that food producers and traders “are the first persons responsible for food safety.” The update also specifies that the Food and Drug Regulatory Department is responsible for food safety […]

McKinsey & Co. and the China Pharmaceutical Association forecast China’s retail pharmaceutical sales to increase 17% per year through 2020 to nearly CNY 1.9 trillion ($30.1 billion) in their base case scenario. In 2012, China accounted for 3.8% of sales on average for the top 10 multinational drug firms, compared with 3.0% in 2011. In […]

Spending on science is set to increase for the first time since 2009 under Spain’s fiscal 2014 budget proposal. The country’s R&D budget had declined 39%, excluding inflation, over the five-year period. Nondefense R&D spending would rise 6.1%, while defense R&D spending would increase 39.5% to make up for two consecutive years of declines. A […]

India’s estimated gross expenditure on R&D in current prices grew 17.0% in 2012 to INR 72,620.44 crores ($13.6 billion) to make up 0.88% of GDP. R&D expenditures by the central sector, which consisted of central government departments and public sector/joint sector companies, accounted for 59% of total R&D expenditures and grew 16.0%. Private sector R&D […]